F. Buchegger

F. Buchegger, R. Sutherland, V. Langmuir, 1991, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

A balanced deoxyribonucleoside mixture increased the rate of DNA incorporation of 5-[125I]Iodo-2'-deoxyuridine in glioblastoma cells.

Y. Dupertuis, F. Buchegger, C. Pichard, 2003, Cancer biotherapy & radiopharmaceuticals.

Preclinical Auger and gamma radiation dosimetry for fluorodeoxyuridine-enhanced tumour proliferation scintigraphy with [123I]iododeoxyuridine

Y. Dupertuis, D. Slosman, N. de Tribolet, 2003, European Journal of Nuclear Medicine and Molecular Imaging.

Fluorodeoxyuridine improves imaging of human glioblastoma xenografts with radiolabeled iododeoxyuridine.

Y. Dupertuis, D. Slosman, N. de Tribolet, 2001, Cancer research.

C-ACETATE PET/CT AT EARLY PSA RELAPSE AFTER PROSTATECTOMY

H. Zaidi, R. Miralbell, F. Buchegger, 2007 .

PET/CT imaging and the oligometastatic prostate cancer patient: an opportunity for a curative approach with high-dose radiotherapy?

R. Miralbell, F. Buchegger, 2014, European Journal of Nuclear Medicine and Molecular Imaging.

Combined radioimmunotherapy and chemotherapy of human colon carcinoma grafted in nude mice, advantages and limitations.

F. Buchegger, A. Pèlegrin, J. Mach, 1992, Anticancer research.

Radioimmunotherapy of Colorectal Cancer Liver Metastases: Combination with Radiotherapy

A. Allal, Y. Dupertuis, D. Slosman, 2000, Annals of the New York Academy of Sciences.

Carcinoembryonic antigen expression, antibody localisation and immunophotodetection of human colon cancer liver metastases in nude mice: A model for radioimmunotherapy

D. Slosman, F. Buchegger, A. Pèlegrin, 1996, International journal of cancer.

Ablation of human colon carcinoma in nude mice by 131I-labeled monoclonal anti-carcinoembryonic antigen antibody F(ab')2 fragments.

F. Buchegger, F. Prével, J. Mach, 1989, The Journal of clinical investigation.

Higher efficiency of 131I-labeled anti-carcinoembryonic antigen-monoclonal antibody F(ab')2 as compared to intact antibodies in radioimmunotherapy of established human colon carcinoma grafted in nude mice.

F. Buchegger, A. Pèlegrin, J. Mach, 1996, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

Bone marrow dosimetry in rats using direct tissue counting after injection of radio-iodinated intact monoclonal antibodies or F(ab')2 fragments.

F. Buchegger, A. Pèlegrin, J. Mach, 1991, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Iodine-131-labeled MAb F(ab')2 fragments are more efficient and less toxic than intact anti-CEA antibodies in radioimmunotherapy of large human colon carcinoma grafted in nude mice.

F. Buchegger, A. Pèlegrin, J. Mach, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Cancer Therapy : Preclinical Pretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma

P. Stayton, J. Pagel, F. Buchegger, 2011 .

Pretargeted Radioimmunotherapy Using Genetically Engineered Antibody-Streptavidin Fusion Proteins for Treatment of Non-Hodgkin Lymphoma

P. Stayton, J. Pagel, F. Buchegger, 2011, Clinical Cancer Research.

Title : Pretargeted radioimmunotherapy using genetically engineered antibody-streptavidin fusion proteins for treatment of non-hodgkin lymphoma

S. Wilbur, P. Stayton, F. Buchegger, 2022 .

68Ga-NODAGA-RGDyK for αvβ3 integrin PET imaging

John O. Prior, C. Rüegg, F. Buchegger, 2011, Nuklearmedizin.

Detection of colorectal carcinoma by emission-computerized tomography after injection of 123I-labeled Fab or F(ab')2 fragments from monoclonal anti-carcinoembryonic antigen antibodies.

F. Buchegger, J. Mach, J. Pettavel, 1986, The Journal of clinical investigation.

Different behaviour of mouse‐human chimeric antibody F(ab')2 fragments of IgG1, IgG2 and IgG4 sub‐class in vivo

C. Heusser, F. Buchegger, W. Dolci, 1992, International journal of cancer.

[Immunotargeting of tumors: state of the art and prospects in 2000].

B. Robert, L. Leserman, F. Buchegger, 2000, Bulletin du cancer.

Expression of the DF3-P epitope in human ovarian carcinomas.

L. Perey, D. Kufe, F. Buchegger, 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.

Repeated injections of 131I-rituximab show patient-specific stable biodistribution and tissue kinetics

F. Verdun, F. Buchegger, T. Kovacsovics, 2005, European Journal of Nuclear Medicine and Molecular Imaging.

In vivo localization of a bispecific antibody which targets human t lymphocytes to lyse human colon cancer cells

S. Miescher, I. Barr, A. Lanzavecchia, 1989, International journal of cancer.

Lysis of tumor cells by the retargeting of murine cytolytic T lymphocytes with bispecific antibodies

I. Barr, H. Macdonald, F. Buchegger, 1987, International journal of cancer.

Selective tumor localization of radiolabeled anti‐human melanoma monoclonal antibody fragment demonstrated in the nude mouse model

F. Buchegger, J. Mach, S. Carrel, 1986, Cancer.

Potential contribution of 131I-labelled monoclonal anti-CEA antibodies in the treatment of liver metastases from colorectal carcinomas: pretherapeutic study with dose recovery in resected tissues.

M. Ychou, P. Rougier, F. Eschwège, 1993, European journal of cancer.

Cancer detection by immunoscintigraphy, selection, and clinical application of monoclonal anti-CEA antibodies and their F(ab')2 or Fab fragments.

F. Buchegger, J. Mach, J. Pettavel, 1986, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

First imaging results of an intraindividual comparison of 11C-acetate and 18F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy

H. Zaidi, O. Ratib, Y. Seimbille, 2013, European Journal of Nuclear Medicine and Molecular Imaging.

Imaging of human leukemic T‐Cell Xenografts in nude mice by radiolabeled monoclonal antibodies and F(ab')2 fragments

F. Buchegger, A. Vacca, J. Mach, 1988, Cancer.

Radioimmuno positron emission tomography with monoclonal antibodies: A new approach to quantifying in vivo tumour concentration and biodistribution for radioimmunotherapy

G. V. von Schulthess, C. Heusser, F. Buchegger, 1991, Nuclear medicine communications.

Design and synthesis of bis-biotin-containing reagents for applications utilizing monoclonal antibody-based pretargeting systems with streptavidin mutants.

J. Pagel, F. Buchegger, D. Hamlin, 2010, Bioconjugate chemistry.

The preparation of clinical grade 5-[123I]iodo-2′-deoxyuridine and 5-[125I]iodo-2′-deoxyuridine with high in vitro stability and the potential for early proliferation scintigraphy

Y. Dupertuis, F. Buchegger, A. Delaloye, 2004, Nuclear medicine communications.

Radioimmunotherapy and fractionated radiotherapy of human colon cancer liver metastases in nude mice.

F. Buchegger, C. Vogel, M. Galmiche, 1997, Cancer research.

Imaging of inflammatory and infectious lesions after injection of radioiodinated monoclonal anti-granulocytes antibodies.

F. Buchegger, P. Schubiger, J. Locher, 1986, Nuclear medicine communications.

Clinical value of immunoscintigraphy in colorectal carcinoma patients: a prospective study.

F. Buchegger, J. Givel, J. Mach, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Long-term Results of a Comparative PET/CT and PET/MRI Study of 11C-Acetate and 18F-Fluorocholine for Restaging of Early Recurrent Prostate Cancer

H. Zaidi, O. Ratib, Y. Seimbille, 2017, Clinical nuclear medicine.

Recurrent Prostate Cancer

H. Zaidi, O. Ratib, Y. Seimbille, 2017 .

Expression of a functional single chain antibody on the surface of extracellular enveloped vaccinia virus as a step towards selective tumour cell targeting.

W. Wels, F. Buchegger, R. Wittek, 1997, The Journal of general virology.

Generation of a recombinant mouse‐human chimaeric monoclonal antibody directed against human carcinoembryonic antigen

C. Heusser, K. Wagner, F. Buchegger, 1989, International journal of cancer.

Direct comparison of a radioiodinated intact chimeric anti-CEA MAb with its F(ab')2 fragment in nude mice bearing different human colon cancer xenografts.

F. Buchegger, A. Pèlegrin, C. Vogel, 1993, British Journal of Cancer.

In the present study, we have measured bone marrow radioactivity using direct counting of tissues from normal rats and from tumor-bearing nude rats after intravenous injection ofradiolabeled intact Mabs or F(ab')2 fragments

F. Buchegger, A. Pèlegrin, J. Mach, 2006 .

Six of 12 Relapsed or Refractory Indolent Lymphoma Patients Treated 10 Years Ago with 131I-Tositumomab Remain in Complete Remission

John O. Prior, F. Buchegger, A. Delaloye, 2011, The Journal of Nuclear Medicine.

13II-Anticarcinoembryonic Antigen Therapy of LS174T Human Colon Adenocarcinoma Spheroids1

F. Buchegger, R. Sutherland, V. Langmuir, 2006 .

II-Anticarcinoembryonic Antigen Therapy of LS 174 T Human Colon Adenocarcinoma Spheroids 1

F. Buchegger, K. McGann, R. Sutherland, 2006 .

Human carcinoembryonic antigen cDNA expressed in rat carcinoma cells can function as target antigen for tumor localization of antibodies in nude rats and as rejection antigen in syngeneic rats

K. Schwarz, D. Hayoz, Monique Martin, 1992, International journal of cancer.

Immunoscintigraphy for the detection of human carcinoma after injection of radiolabeled monoclonal anti-carcinoembryonic antigen antibodies.

M. Forni, R. Egley, F. Buchegger, 1983, Current topics in microbiology and immunology.

The human Ia-associated invariant chain is synthesized in Ia-negative B cell variants and is not expressed on the cell surface of both Ia-negative and Ia-positive parental cells.

F. Buchegger, J. Mach, R. Accolla, 1985, Journal of immunology.

Functional analysis of human/chicken transferrin receptor chimeras indicates that the carboxy-terminal region is important for ligand binding.

S. White, L. Liu, I. Trowbridge, 1996, European journal of biochemistry.

Biokinetics of a F(ab')3 iodine-131 labeled antigen binding construct (Mab 35) directed against CEA in patients with colorectal carcinoma.

R. Offord, F. Buchegger, P. Schubiger, 2001, Cancer biotherapy & radiopharmaceuticals.

Characterization of a monoclonal antibody (A12) that defines a human acute lymphoblastic leukemia-associated differentiation antigen.

R. Sékaly, D. Heumann, F. Buchegger, 1983, Hybridoma.

90Y Time-of-flight PET/MR on a hybrid scanner following liver radioembolisation (SIRT)

H. Zaidi, O. Ratib, M. Viallon, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

Immunoscintigraphy with biosynthetically-labeled 75Se-antibodies--I. Biodistribution of 75Se-monoclonal antibodies and of free radionuclide.

J. Ryser, F. Buchegger, A. Donath, 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Immunoscintigraphy with biosynthetically-labeled 75Se-antibodies--II. Comparison with antibodies labeled by radioiodination.

J. Ryser, F. Buchegger, A. Donath, 1990, International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology.

Immunoscintigraphic localization of inflammatory lesions concept, radiolabelling and in vitro testing of a granulocyte specific antibody

F. Buchegger, P. Schubiger, J. Locher, 2007, European Journal of Nuclear Medicine.

Multiple Frame 18F-Fluorocholine or 11C-Acetate PET/CT Compared with Multi-modality MRI in Prostate Cancer Patients after Curative RT without Evidence of Relapse

O. Ratib, R. Miralbell, F. Buchegger, 2009 .

Effect of peroxisome proliferator-activated receptor &ggr; agonist, rosiglitazone, on dedifferentiated thyroid cancers

F. Buchegger, C. Meier, J. Philips, 2004, Nuclear medicine communications.

Use of limitations of radiolabeled anti-CEA antibodies and their fragments for photoscanning detection of human colorectal carcinomas.

M. Forni, F. Buchegger, J. Mach, 1980, Oncodevelopmental biology and medicine : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Fractionated Irradiation Combined with Carbogen Breathing and Nicotinamide of Two Human Glioblastomas Grafted in Nude Mice

R. Mirimanoff, F. Buchegger, Lin-Quan Sun, 2001, Radiation research.

Fractionated Radiotherapy of Human Colon Cancer Liver Metastases in Nude Mice 1

F. Buchegger, C. Vogel, Marie C. Gahniche, 2006 .

Tumor‐necrosis factor can enhance radio‐antibody uptake in human colon carcinoma xenografts by increasing vascular permeability

F. Buchegger, J. Mach, S. Folli, 1993, International journal of cancer.

TAT-RasGAP317–326 Enhances Radiosensitivity of Human Carcinoma Cell Lines In Vitro and In Vivo through Promotion of Delayed Mitotic Cell Death

J. Bourhis, C. Widmann, F. Buchegger, 2017, Radiation Research.

Improving the chance of cure of follicular lymphoma by combining immunotherapy and radioimmunotherapy based on anti-CD20 antibodies?

John O. Prior, S. Larson, F. Buchegger, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

PET Molecular Imaging of Hypoxia in Ischemic Stroke: An Update.

O. Ratib, Y. Seimbille, V. Garibotto, 2014, Current vascular pharmacology.

131I-anticarcinoembryonic antigen therapy of LS174T human colon adenocarcinoma spheroids.

F. Buchegger, R. Sutherland, V. Langmuir, 1989, Cancer research.

Short fluorodeoxyuridine exposure of different human glioblastoma lines induces high-level accumulation of S-phase cells that avidly incorporate 125I-iododeoxyuridine

Y. Dupertuis, F. Buchegger, A. Bischof Delaloye, 2006, European Journal of Nuclear Medicine and Molecular Imaging.

Highly efficient DNA incorporation of intratumourally injected [125I]iododeoxyuridine under thymidine synthesis blocking in human glioblastoma xenografts

Y. Dupertuis, N. de Tribolet, F. Buchegger, 2004, International journal of cancer.

Magnetic and in vitro heating properties of implants formed in situ from injectable formulations and containing superparamagnetic iron oxide nanoparticles (SPIONs) embedded in silica microparticles for magnetically induced local hyperthermia

C. Senatore, H. Hofmann, A. Petri‐Fink, 2011 .

Formulations for Local, Magnetically Mediated Hyperthermia Treatment of Solid Tumors

A. Petri‐Fink, F. Buchegger, E. Doelker, 2012 .

Vitamin E content in fish oil emulsion does not prevent lipoperoxidative effects on human colorectal tumors.

C. Pichard, Y. Dupertuis, F. Buchegger, 2013, Nutrition.

Omega-3 polyunsaturated fatty acids and ionizing radiation: combined cytotoxicity on human colorectal adenocarcinoma cells.

C. Pichard, A. Allal, Y. Dupertuis, 2006, Nutrition.

Basic nutritional investigation -3 Polyunsaturated fatty acids and ionizing radiation: combined cytotoxicity on human colorectal adenocarcinoma cells

C. Pichard, A. Allal, Y. Dupertuis, 2006 .

Penetration and binding of radiolabeled anti-carcinoembryonic antigen monoclonal antibodies and their antigen binding fragments in human colon multicellular tumor spheroids.

F. Buchegger, R. Sutherland, A. Vacca, 1987, Cancer research.

Monoclonal Antibodies and a Streptavidin-Biotin System Used in an Enzyme Immunoassay for Carcinoembryonic Antigen

F. Buchegger, C. Haskell, J. Mach, 1984 .

Tomoscintigraphy for detecting gastrointestinal and medullary thyroid cancers: first clinical results using radiolabelled monoclonal antibodies against carcinoembryonic antigen.

C. Langlais, P. Rougier, M. Tubiana, 1982, British medical journal.

Monoclonal Antibodies in the Diagnosis and Management of Colorectal Carcinomas

F. Buchegger, J. Mach, J. Pettavel, 1989 .

Antigenic Sites in Carcinoembryonic Antigen 1

Christoph, Masahide, R. Paxton, 2006 .

Antigenic sites in carcinoembryonic antigen.

R. Paxton, B. Beatty, J. Shively, 1989, Cancer research.

Monoclonal antibodies identify a cea crossreacting antigen of 95 kD (NCA‐95) distinct in antigenicity and tissue distribution from the previously described NCA of 55 kD

F. Buchegger, J. Mach, M. Schreyer, 1984, International journal of cancer.

Radiolabeled fragments of monoclonal antibodies against carcinoembryonic antigen for localization of human colon carcinoma grafted into nude mice

F. Buchegger, C. Haskell, J. Mach, 1983, The Journal of experimental medicine.

Use of radiolabelled monoclonal anti-CEA antibodies for the detection of human carcinomas by external photoscanning and tomoscintigraphy.

M. Forni, J. Lumbroso, F. Buchegger, 1981, Immunology today.

Radioimmunotherapy of human colon carcinoma by 131I‐labelled monoclonal anti‐cea antibodies in a nude mouse model

A Vacca, F. Buchegger, A. Vacca, 1988, International Journal of Cancer.

Radioimmunotherapy Combined with Maintenance Anti-CD20 Antibody May Trigger Long-Term Protective T Cell Immunity in Follicular Lymphoma Patients

John O. Prior, S. Larson, D. Speiser, 2013, Clinical & developmental immunology.

Monoclonal antibodies to carcinoembryonic antigen: ionic strength as a factor in the selection of antibodies for immunoscintigraphy.

F. Buchegger, C. Haskell, J. Mach, 1983, Cancer research.

Tumor localization in patients by radiolabeled monoclonal antibodies against colon carcinoma.

M. Herlyn, M. Forni, J. Douillard, 1983, Cancer research.

Monoclonal antibody against carcinoembryonic antigen (CEA) identifies two new forms of crossreacting antigens of molecular weight 90,000 and 160,000 in normal granulocytes.

F. Buchegger, J. Mach, M. Schreyer, 1987, Molecular immunology.

Positive interactive radiosensitisation in vitro with the combination of two nucleoside analogues, (E)-2'-deoxy-2'-(fluoromethylene) cytidine and iododeoxyuridine.

P. Coucke, L. Decosterd, P. Martineau, 2004, European journal of cancer.

Charge dependent substrate activity of C3' and N3 functionalized, organometallic technetium and rhenium-labeled thymidine derivatives toward human thymidine kinase 1.

R. Schibli, F. Buchegger, B. Spingler, 2010, Bioconjugate chemistry.

Unlabelled iododeoxyuridine increases the rate of uptake of [125I]iododeoxyuridine in human xenografted glioblastomas

C. Pichard, Y. Dupertuis, D. Slosman, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

Unlabelled iododeoxyuridine increases the cytotoxicity and incorporation of [125I]-iododeoxyuridine in two human glioblastoma cell lines

Y. Dupertuis, N. de Tribolet, F. Buchegger, 2000, Nuclear medicine communications.

Rapid Publication Detection of the Common Acute Lymphoblastic Leukemia Antigen in the Serum of Leukemia Patients

G. Losa, D. Heumann, F. Buchegger, 2013 .

Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence

H. Zaidi, O. Ratib, R. Miralbell, 2008, Nuklearmedizin.

Induction of an immune response through the idiotypic network with monoclonal anti‐idiotype antibodies in the carcinoembryonic antigen system

F. Buchegger, J. Mach, J. D. Lopes, 1992, Journal of cellular biochemistry.

Fluorodeoxyuridine mediated cell cycle synchronization in S-phase increases the Auger radiation cell killing with 125I-iododeoxyuridine

Y. Dupertuis, F. Buchegger, A. Bischof Delaloye, 2009, Nuklearmedizin.

Nanomedicines for active targeting: physico-chemical characterization of paclitaxel-loaded anti-HER2 immunonanoparticles and in vitro functional studies on target cells.

R. Gurny, F. Buchegger, F Delie, 2009, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Combined effects of interleukin-3 and interleukin-11 on hematopoiesis in irradiated mice.

F. Buchegger, A. Delaloye, C. Vogel, 1996, Experimental hematology.

Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice.

R. Gurny, F. Buchegger, N. Lange, 2010, Journal of controlled release : official journal of the Controlled Release Society.

Current methods for attaching targeting ligands to liposomes and nanoparticles.

Robert Gurny, Eric Allémann, Franz Buchegger, 2004, Journal of pharmaceutical sciences.

Reference [ ( 18 ) F ] Fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma

H. Zaidi, O. Ratib, R. Miralbell, 2017 .

Fluoroethyltyrosine-positron emission tomography-guided radiotherapy for high-grade glioma

H. Zaidi, O. Ratib, R. Miralbell, 2008 .

[(18)F]Fluoroethyltyrosine- positron emission tomography-guided radiotherapy for high-grade glioma

Habib Zaidi, Michel Rouzaud, Osman Ratib, 2008, Radiation oncology.

Radioimmunotherapy consolidation and rituximab maintenance in the initial treatment of follicular lymphoma

F. Buchegger, O. Press, 2011, EJNMMI research.

The in vivo performance of magnetic particle-loaded injectable, in situ gelling, carriers for the delivery of local hyperthermia.

D. Rüfenacht, H. Hofmann, A. Petri‐Fink, 2010, Biomaterials.

Sentinel lymph node involvement and a high Breslow index are independent factors of risk for early relapse of melanoma

R. Braun, F. Buchegger, B. Roche, 2007, Nuklearmedizin.

Expression of nonspecific cross-reacting antigen species in myeloid leukemic patients and healthy subjects

F. Buchegger, A. Harłozińska, A. Noworolska, 1989, Blut.

Radiolabeled and native antibodies and the prospect of cure of follicular lymphoma.

F. Buchegger, A. Delaloye, O. Press, 2008, The oncologist.

Antitumour effects of single or combined monoclonal antibodies directed against membrane antigens expressed by human B cells leukaemia

S. Loisel, F. Buchegger, A. Delaloye, 2011, Molecular Cancer.

Differential tumor cell targeting of anti-HER2 (Herceptin) and anti-CD20 (Mabthera) coupled nanoparticles.

R. Gurny, F. Buchegger, F Delie, 2007, International journal of pharmaceutics.

Long-term complete responses after 131I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphoma

F. Buchegger, T. Kovacsovics, A. Delaloye, 2006, British Journal of Cancer.

Surface modification of poly(lactic acid) nanoparticles by covalent attachment of thiol groups by means of three methods.

Robert Gurny, Eric Allémann, Franz Buchegger, 2003, International journal of pharmaceutics.

Increase of [18F]FLT Tumor Uptake In Vivo Mediated by FdUrd: Toward Improving Cell Proliferation Positron Emission Tomography

R. Gruetter, S. Ametamey, H. Lehr, 2011, Molecular Imaging and Biology.

RESEARCH ARTICLE Increase of ( 18 F)FLT Tumor Uptake In Vivo Mediated by FdUrd: Toward Improving Cell Proliferation Positron Emission Tomography

R. Gruetter, S. Ametamey, H. Lehr, 2010 .

[CERN-MEDICIS (Medical Isotopes Collected from ISOLDE): a new facility].

Osman Ratib, Philippe Morel, David Viertl, 2014, Revue medicale suisse.

Combined radioimmunotherapy and radiotherapy of liver metastases from colorectal cancer: a feasibility study.

R. Mirimanoff, A. Allal, Y. Dupertuis, 2000, Anticancer research.

Progress in Diagnostic Immunoscintigraphy and First Approach to Radioimmunotherapy of Colon Carcinoma

S. Leyvraz, F. Buchegger, J. Givel, 1988 .

Immunoscintigraphy of CEA-Producing Tumors with Special Emphasis on the Use of Mab Fragments and ECT

F. Buchegger, J. Mach, A. Bischof-Delaloye, 1986 .

Three-dimensional radiobiological dosimetry of kidneys for treatment planning in peptide receptor radionuclide therapy.

Eric C Frey, George Sgouros, Ariane Boubaker, 2012, Medical physics.

Phase‐I/II radio‐immunotherapy study with iodine‐131‐labeled anti‐CEA monoclonal antibody F6 F(ab′)2 in patients with non‐resectable liver metastases from colorectal cancer

J. Rossi, M. Ychou, B. Robert, 1998, International journal of cancer.

Targeted alpha therapy in vivo: direct evidence for single cancer cell kill using 149Tb-rituximab

F. Buchegger, R. Senekowitsch-Schmidtke, M. Miederer, 2004, European Journal of Nuclear Medicine and Molecular Imaging.

Auger radiation targeted into DNA: a therapy perspective

Franz Buchegger, Y. Dupertuis, F. Buchegger, 2006, European Journal of Nuclear Medicine and Molecular Imaging.

Local moderate magnetically induced hyperthermia using an implant formed in situ in a mouse tumor model

D. Rüfenacht, H. Hofmann, A. Petri‐Fink, 2009, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Poly(lactic acid) nanoparticles labeled with biologically active Neutravidin for active targeting.

Robert Gurny, Eric Allémann, Franz Buchegger, 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

18F-FLT and 125I-IdUrd uptake increase in human tumour cell lines induced by the thymidylate synthase inhibitor FdUrd

S. Ametamey, Y. Dupertuis, F. Buchegger, 2012, Nuklearmedizin.

11C-acetate PET in the early evaluation of prostate cancer recurrence

Habib Zaidi, Osman Ratib, Dmitri Soloviev, 2007, European Journal of Nuclear Medicine and Molecular Imaging.

First in-human radiation dosimetry of 68Ga-NODAGA-RGDyK

John O. Prior, A. Gallino, F. Buchegger, 2017, EJNMMI Research.

Biodistribution of anti‐CEA F(ab′')2 fragments after intra‐arterial and intravenous injection in patients with liver metastases due to colorectal carcinoma

C. Achtari, F. Doenz, F. Buchegger, 1996, Nuclear medicine communications.

Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients

O. Ratib, R. Miralbell, V. Garibotto, 2015, Nuklearmedizin.

In vivo localisation of radiolabelled monoclonal antibody in human gliomas.

N. de Tribolet, F. Buchegger, J. Mach, 1988, British journal of neurosurgery.

Retargeting of cytolytic T lymphocytes by heteroaggregated (bispecific) antibodies.

I. Barr, H. Macdonald, F. Buchegger, 1988, Cancer Detection and Prevention.

Carcinoembryonic Antigen Specificity and Affinity of Monoclonal Antibodies against Updated

R. Holm, M. Nap, C. Wagener, 2006 .

Target volume definition in high-risk prostate cancer patients using sentinel node SPECT/CT and 18 F-choline PET/CT

O. Ratib, R. Miralbell, F. Buchegger, 2012, Radiation oncology.

131I-rituximab: relationship between immunoreactivity and specific activity.

F. Buchegger, A. Delaloye, M. Kosiński, 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A pitfall of propidium iodide staining in fluorescence-activated cell sorting cell cycle analysis?

Y. Dupertuis, F. Buchegger, F. Perillo-Adamer, 2007, Cancer research.

Tumor targeting with newly designed biparatopic antibodies directed against two different epitopes of the carcinoembryonic antigen (CEA)

B. Robert, F. Buchegger, A. Pèlegrin, 1999, International journal of cancer.

Radiolabeled neurotensin analog, 99mTc-NT-XI, evaluated in ductal pancreatic adenocarcinoma patients.

Franz Buchegger, J. Reubi, F. Buchegger, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Biodegradable nanoparticles for direct or two-step tumor immunotargeting.

R. Gurny, F. Buchegger, E. Allémann, 2006, Bioconjugate chemistry.

A novel derivative of the chelon desferrioxamine for site‐specific conjugation to antibodies

K. Rose, R. Offord, J. Ryser, 1989, International journal of cancer.

Long-Term Post-Treatment MR and PET/CT Imaging in Prostate Cancer Patients in Complete Remission after Curative Radiotherapy with or without Androgen Deprivation: The Image of Cure

O. Ratib, Y. Seimbille, R. Miralbell, 2012 .

High efficiency production and purification of 86Y based on electrochemical separation.

Y. Seimbille, F. Buchegger, C. Tamburella, 2009, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Biokinetics and dosimetry of 111In-DOTA-NOC-ATE compared with 111In-DTPA-octreotide

John O. Prior, F. Buchegger, A. Bischof Delaloye, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

EFFECT OF SIZE OF RADIOLABELED ANTIBODY AND FRAGMENTS ON TUMOR UPTAKE AND DISTRIBUTION IN NEPHRECTOMIZED MICE

F. Buchegger, S. Halpern, M. Schreyer, 1984 .

In Vitro and In Vivo Tumor Models for Studies of Distribution of Radiolabelled Monoclonal Antibodies and Fragments

F. Buchegger, R. Sutherland, J. Mach, 1986, Nuklearmedizin.

[11C]acetate PET/CT Visualizes Skeletal Muscle Exercise Participation, Impaired Function, and Recovery after Hip Arthroplasty; First Results

Habib Zaidi, Osman Ratib, Yann Seimbille, 2010, Molecular Imaging and Biology.

RESEARCH ARTICLE ( 11 C)acetate PET/CT Visualizes Skeletal Muscle Exercise Participation, Impaired Function, and Recovery after Hip Arthroplasty; First Results

H. Zaidi, O. Ratib, Y. Seimbille, 2011 .

SPECT with I-123 labeled F(ab')/sub 2/ fragments from monoclonal anti-CEA antibodies in colon carcinoma

F. Buchegger, J. Mach, A. Bischof-Delaloye, 1984 .

68 Ga-NODAGA-RGDyK for α v β 3 integrin PET imaging Preclinical investigation and dosimetry

John O. Prior, F. Buchegger, V. Dunet, 2017 .

MONOCLONAL ANTIBODIES IDENTIFY A CEA CROSSREACTING TISSUE DISTRIBUTION FROM THE PREVIOUSLY DESCRIBED NCA OF 55 kD ANTIGEN OF 95 kD (NCA-95) DISTINCT IN ANTIGENICITY AND

F. Buchegger, J. Mach, M. Schreyer, 2006 .

Localisation of Tumor-Associated Antigens on Sections of Human Colon Carcinoma Grafted into Nude Mice with Mouse Monoclonal Antibodies Using the Avidin-Biotin-Immunoperoxidase Reaction

F. Buchegger, C. Girardet, C. Haskell, 1984 .

Site-specific conjugation of a radioiodinated phenethylamine derivative to a monoclonal antibody results in increased radioactivity localization in tumor.

F. Buchegger, M. Kurth, André Pèlegrin, 1993, Journal of medicinal chemistry.

High efficiency production and purification of 86Y based on electrochemical separation.

Y. Seimbille, F. Buchegger, C. Tamburella, 2009, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine.

Long-term complete responses after 131I-tositumomab therapy for relapsed or refractory indolent non-Hodgkin's lymphoma

F. Buchegger, A. Delaloye, M. Kosiński, 2006, British Journal of Cancer.